The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.
Trump
Administration
Supported by
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.
By Rebecca RobbinsChristina Jewett and Dani Blum
The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information…
President Donald Trump has signed a memorandum launching a crackdown on misinformation in drug advertisements.
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over…
While the most favored nation initiatives have bold aims to lower the cost of drugs, the impact is limited, and in some instances…
US president has said that he will use tariffs to bring down costly medical drugs, but the impact remains uncertain.
Although Trump is taking steps to investigate insurer and PBM practices, it's time for him to crack down on these bad actors once…
